UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review

International journal of molecular sciences, 2023-02, Vol.24 (4), p.4097

2023

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis

Journal of cellular and molecular medicine, 2010-06, Vol.14 (6a), p.1241-1254

2010

Link zum Volltext

Verfügbarkeit prüfen

Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?

Annals of the rheumatic diseases, 2014-09, Vol.73 (9), p.1700-1709

2014

Link zum Volltext

Verfügbarkeit prüfen

The crowded crossroad to angiogenesis in systemic sclerosis: where is the key to the problem?

Arthritis research & therapy, 2016-02, Vol.18 (36), p.36-36, Article 36

2016

Link zum Volltext

Verfügbarkeit prüfen

Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of systemic sclerosis endothelial cells

Rheumatology (Oxford, England), 2023-02, Vol.62 (SI), p.SI125-SI137

2023

Link zum Volltext

Verfügbarkeit prüfen

Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis

PloS one, 2017-08, Vol.12 (8), p.e0183102-e0183102

2017

Link zum Volltext

Verfügbarkeit prüfen

The "myth" of loss of angiogenesis in systemic sclerosis: a pivotal early pathogenetic process or just a late unavoidable event?

Arthritis research & therapy, 2017-07, Vol.19 (1), p.162-162, Article 162

2017

Link zum Volltext

Verfügbarkeit prüfen

Circulating Neurovascular Guidance Molecules and Their Relationship with Peripheral Microvascular Impairment in Systemic Sclerosis

Life (Basel, Switzerland), 2022-07, Vol.12 (7), p.1056

2022

Link zum Volltext

Verfügbarkeit prüfen

Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide

PloS one, 2015-06, Vol.10 (6), p.e0130166-e0130166

2015

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of VEGF165b, an Inhibitory Splice Variant of Vascular Endothelial Growth Factor, Leads to Insufficient Angiogenesis in Patients With Systemic Sclerosis

Circulation research, 2011-07, Vol.109 (3), p.e14-e26

2011

Link zum Volltext

Verfügbarkeit prüfen

Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis

Rheumatology (Oxford, England), 2021-10, Vol.60 (10), p.4508-4519

2021

Link zum Volltext

Verfügbarkeit prüfen

Impaired Angiogenesis in Systemic Sclerosis: The Emerging Role of the Antiangiogenic VEGF165b Splice Variant

Trends in cardiovascular medicine, 2011-10, Vol.21 (7), p.204-210

2011

Link zum Volltext

Verfügbarkeit prüfen

Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro

Annals of the rheumatic diseases, 2011-11, Vol.70 (11), p.2011-2021

2011

Link zum Volltext

Verfügbarkeit prüfen

Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage

Annals of the rheumatic diseases, 2012-06, Vol.71 (6), p.1064-1072

2012

Link zum Volltext

Verfügbarkeit prüfen

Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis

Autoimmunity reviews, 2015-04, Vol.14 (4), p.314-322

2015

Link zum Volltext

Verfügbarkeit prüfen

Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis

Annals of the rheumatic diseases, 2019-04, Vol.78 (4), p.575

2019

Link zum Volltext

Verfügbarkeit prüfen

Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells

Arthritis research & therapy, 2017-02, Vol.19 (1), p.27-27, Article 27

2017

Link zum Volltext

Verfügbarkeit prüfen

Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence

International journal of molecular sciences, 2019-12, Vol.20 (24), p.6189

2019

Link zum Volltext

Verfügbarkeit prüfen

Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study

Clinical and experimental rheumatology, 2015-07, Vol.33 (4 Suppl 91), p.S148

2015

Link zum Volltext

Verfügbarkeit prüfen

The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis

Annals of the rheumatic diseases, 2010-03, Vol.69 (3), p.598-605

2010

Link zum Volltext

Verfügbarkeit prüfen

Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report

Annals of internal medicine, 2010-11, Vol.153 (10), p.650

2010

Link zum Volltext

Verfügbarkeit prüfen

Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement

Annals of the rheumatic diseases, 2011-10, Vol.70 (10), p.1876-1878

2011

Link zum Volltext

Verfügbarkeit prüfen

Differential expression of junctional adhesion molecules in different stages of systemic sclerosis

Arthritis and rheumatism, 2013-01, Vol.65 (1), p.247-257

2013

Link zum Volltext

Verfügbarkeit prüfen

A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis

Arthritis and rheumatism, 2011-01, Vol.63 (1), p.247-256

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

ThemaAngiogenesis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Humans
(21)
Life Sciences & Biomedicine
(20)
Rheumatology
(16)
Systemic Sclerosis
(15)
Female
(14)
Male
(12)
Scleroderma, Systemic - Pathology
(12)
Scleroderma
(11)
Middle Aged
(10)
Adult
(9)
Aged
(8)
Endothelial Cells - Metabolism
(8)
Scleroderma, Systemic - Metabolism
(8)
Vascular Endothelial Growth Factor
(8)
Cells, Cultured
(7)
Endothelial Cells
(7)
Fibroblasts
(7)
Neovascularization, Pathologic - Pathology
(7)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review

Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis

Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?

The crowded crossroad to angiogenesis in systemic sclerosis: where is the key to the problem?

Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of systemic sclerosis endothelial cells

Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis

The "myth" of loss of angiogenesis in systemic sclerosis: a pivotal early pathogenetic process or just a late unavoidable event?

Circulating Neurovascular Guidance Molecules and Their Relationship with Peripheral Microvascular Impairment in Systemic Sclerosis

Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide

Overexpression of VEGF165b, an Inhibitory Splice Variant of Vascular Endothelial Growth Factor, Leads to Insufficient Angiogenesis in Patients With Systemic Sclerosis

Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis

Impaired Angiogenesis in Systemic Sclerosis: The Emerging Role of the Antiangiogenic VEGF165b Splice Variant

Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro

Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage

Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis

Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis

Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells

Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence

Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study

The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis

Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report

Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement

Differential expression of junctional adhesion molecules in different stages of systemic sclerosis

A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis

Aktive Filter

Suchergebnisse filtern